Boston Scientific
Trade Boston Scientific 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BSX
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.
BSX Key Statistics
Stock Snapshot
With a market cap of 135.76B, Boston Scientific(BSX) trades at $91.55. The stock has a price-to-earnings ratio of 48.83.
During the trading session on 2026-01-23, Boston Scientific(BSX) shares reached a daily high of $92.34 and a low of $90.89. At a current price of $91.55, the stock is +0.7% higher than the low and still -0.9% under the high.
Trading volume for Boston Scientific(BSX) stock has reached 5.95M, versus its average volume of 13.69M.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.
Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.
BSX News
Boston Scientific (NYSE:BSX) announced a $14.5b agreement to acquire Penumbra, expanding its reach in cardiovascular, neurovascular, and vascular markets. The...
The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE:BSX) has alerted customers to remove certain AXIOS stents...
Tuesday’s total option volume of 68.2 million contracts resulted in net open interest growth of 8.97 million calls and 8.02 million puts. Netflix (NFLX), NVIDIA...
Analyst ratings
95%
of 37 ratingsMore BSX News
Technology J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll Licensing Johnson & Johnson (JNJ) stock toppled early Wednesday after the...
Boston Scientific (BSX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium Study Overview Boston Scientific is launching a f...
Canaccord downgraded Penumbra (PEN) to Hold from Buy with a price target of $374, up from $359. The firm cites Boston Scientific’s (BSX) agreement to acquire Pe...
Advertisement What recent performance says about Boston Scientific (BSX) Boston Scientific (BSX) has been under pressure lately, with the stock showing a 2.2%...